Clinical Trial

Additional Left Atrial Appendage Isolation During Balloon Ablation for Persistent or Long-standing Persistent Atrial Fibrillation

Study acronym: LALA-LAND-AF
Recruiting
View on ClinicalTrials.gov →
Summary
Additional left atrial appendage isolation during balloon ablation for persistent or long-standing persistent atrial fibrillation can reduce atrial fibrillation reoccurrence within 3-12 months compared to balloon-based pulmonary vein isolation only.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-01-23; most recent amendment 2024-08-28.
Trial Details
NCT Number NCT04240366
Lead Sponsor University of Luebeck
Collaborators: IHF GmbH - Institut für Herzinfarktforschung
Conditions Persistent or Long-standing Persistent Atrial Fibrillation
Enrollment 350 participants
Start Date 2019-12-17
Primary Completion 2028-06 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2024-08-29